Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab

Figure 4

(a) Ratio of the well-supported tumor cells () in the case of various therapies; (b) vascularization ratio () in the case of various therapies.

(a)

(b)